Physiological properties of hERG 1a/1b heteromeric currents and a hERG 1b-specific mutation associated with Long-QT syndrome.
about
Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channelsA recombinant N-terminal domain fully restores deactivation gating in N-truncated and long QT syndrome mutant hERG potassium channelsComputer-based prediction of the drug proarrhythmic effect: problems, issues, known and suspected challengesAutonomous beating rate adaptation in human stem cell-derived cardiomyocytes.Mechanistic Insight into Human ether-a-go-go-related Gene (hERG) K+ Channel Deactivation Gating from the Solution Structure of the EAG DomainComputational cardiology: how computer simulations could be used to develop new therapies and advance existing onesMolecular Cloning and Functional Expression of the Equine K+ Channel KV11.1 (Ether à Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine MyocardiumAntiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+ channels in parkinsonian discharges.Cardiac models in drug discovery and development: a review.Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family.Differential expression of hERG1 channel isoforms reproduces properties of native I(Kr) and modulates cardiac action potential characteristics.HERG1 channelopathiesProperties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.hERG 1b is critical for human cardiac repolarizationSig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells.Recapitulation of an ion channel IV curve using frequency componentshERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome.hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.The virtual heart as a platform for screening drug cardiotoxicity.Reduced response to IKr blockade and altered hERG1a/1b stoichiometry in human heart failureThe eag domain regulates hERG channel inactivation gating via a direct interaction.Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentialsDominant negative consequences of a hERG 1b-specific mutation associated with intrauterine fetal death.Cotranslational association of mRNA encoding subunits of heteromeric ion channels.Computational approaches to understand cardiac electrophysiology and arrhythmias.Enhancement of hERG channel activity by scFv antibody fragments targeted to the PAS domainEndocytic control of ion channel density as a target for cardiovascular disease.Long QT syndrome-associated mutations in intrauterine fetal death.Using computational modeling to predict arrhythmogenesis and antiarrhythmic therapy.The voltage-gated channel accessory protein KCNE2: multiple ion channel partners, multiple ways to long QT syndrome.Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.The enigmatic cytoplasmic regions of KCNH channels.hERG subunit composition determines differential drug sensitivity.Proliferative Role of Kv11 Channels in Murine Arteries.Molecular Pathophysiology of Congenital Long QT Syndrome.Effects of Temperature on Heteromeric Kv11.1a/1b and Kv11.3 ChannelsCysteine 723 in the C-linker segment confers oxidative inhibition of hERG1 potassium channels.hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.Functional expression of potassium channels in cardiomyocytes derived from embryonic stem cells.Cysteines control the N- and C-linker-dependent gating of KCNH1 potassium channels.
P2860
Q24301043-0E333539-C000-46EE-80B2-553B10178A1FQ24655800-8D0DF8F1-CCD5-466F-9F22-14FB934FBB53Q26861453-3E32D39D-4F73-4247-B0B4-45ADD7D0DC67Q27335333-FE14C575-F09D-412F-9A92-6056A33F48DCQ27666202-E5E30D9A-52F3-45BA-A00A-39AEEA175BC5Q27694521-323E3E27-6FD1-450E-8683-20B6FADBF22EQ28548072-82F8F5DB-6F60-4EF0-AE10-3F802731D962Q29994716-6663DABB-619B-4F45-AD71-085E59972FFFQ30426852-8DFF0C52-276B-499B-8614-B06D04DE09DCQ33166274-75E50810-0C26-4A70-BD3F-86A185DD86D5Q33528980-32E2E187-FFDC-44A7-BD1E-2B7B9D8F7FB3Q33915930-72FAD8D5-51CE-4DEC-801E-3151EDF0F00CQ33917022-55916C65-2FCD-4C76-9FC0-2982EEE13511Q34752295-0B168E21-88EB-4855-B6DC-EA9D333C37BDQ35150041-D4780F5D-2B7C-4F79-99D8-D7159427EF42Q35396122-4A42B942-4E82-48C2-B2F3-3C2984299C9CQ35581360-87FBEA8B-8A56-4838-842B-9D2F81FCAE43Q36085808-924DBB57-845E-465D-AF42-3B5615596757Q36342116-A90FD9B6-BA94-4144-84A3-631BA2D3ED64Q36381497-5CFFE154-D9FE-4E5A-8E05-48183341A9B4Q36568494-D8B5F08D-08B7-4559-9775-E8B2C3F93EC6Q36629300-1205CA86-D74B-40BF-B343-14D58481945BQ36766298-A00A9BED-6C92-42B0-A786-7F98290AE957Q36866178-A9515F59-E34E-477B-AC7F-C5E7DE41CB50Q37174582-98555B09-C081-41CA-9B33-E7FF96361D70Q37258516-473E558E-B156-45BC-A686-CA75B7818063Q37328506-6217D80E-B478-42A9-B377-40D02D597164Q37367812-8015D7E6-0182-47EE-AAE1-023C0A962ABFQ37774882-E66D00E6-ABF8-4DE1-9746-CE54BB32344AQ37968125-EF57A5C0-1899-4DEC-8531-0B64DFD02FE2Q38201409-4F4D0F41-1623-41E8-A7A6-A23906E7DD27Q38243381-39ADAC8B-CA04-4598-9300-1F53AF684209Q38649960-663347C2-0933-4464-A2EC-C4663057AE30Q38658919-E26065FE-10F3-4471-8C6F-4F06C8C73BDEQ38997049-4662EE8A-88DA-403B-9BCA-1EC54606E956Q39504811-AD9AE2A8-9CA7-4853-B09D-A9279B20C1B7Q39693128-2046EF65-1616-4BB9-A3D0-F602683AD19FQ39842120-05A1FE37-59A7-4C65-95D4-16A10B301059Q41404492-4F87A93E-861E-48A7-8FFC-C89B355CB659Q41817589-330EC686-5F37-47A0-9118-965AE7B16FC6
P2860
Physiological properties of hERG 1a/1b heteromeric currents and a hERG 1b-specific mutation associated with Long-QT syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Physiological properties of hE ...... ociated with Long-QT syndrome.
@en
Physiological properties of hE ...... ociated with Long-QT syndrome.
@nl
type
label
Physiological properties of hE ...... ociated with Long-QT syndrome.
@en
Physiological properties of hE ...... ociated with Long-QT syndrome.
@nl
prefLabel
Physiological properties of hE ...... ociated with Long-QT syndrome.
@en
Physiological properties of hE ...... ociated with Long-QT syndrome.
@nl
P2093
P2860
P1433
P1476
Physiological properties of hE ...... ociated with Long-QT syndrome.
@en
P2093
David J Tester
Gail A Robertson
Harinath Sale
Jia-Qiang He
Jinling Wang
Michael J Ackerman
Pallavi Phartiyal
Thomas J O'Hara
Yoram Rudy
P2860
P304
P356
10.1161/CIRCRESAHA.108.185249
P577
2008-09-05T00:00:00Z